首页>
外国专利>
SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MOLULATING THERAPY TO TREAT AUTOIMMUNE DISEASES AND CANCER
SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MOLULATING THERAPY TO TREAT AUTOIMMUNE DISEASES AND CANCER
展开▼
机译:可溶性白细胞介素7受体(SIL7R)替代疗法治疗自发性疾病和癌症
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention includes compositions and methods for treating an autoimmune disorder or a cancer in a subject in need thereof, the method comprising: administering an effective amount of a composition comprising an oligonucleotide that specifically binds a complementary sequence of the Interleukin-7 receptor (IL7R) pre-mRNA that influences splicing of exon 6, wherein the SM-ASO increases or decreases inclusion of exon 6 in IL7R pre-mRNAs and respectively decreases or increases expression of the soluble isoform of IL7R (sIL7R). In certain embodiments, the oligonucleotide is an antisense oligonucleotide (ASO), or a splice- modulating antisense oligonucleotide (SM-ASO).
展开▼